CMS Open Payments · Program Year 2024
Cortex, Inc.
Cortex, Inc. reported $2,927,840.72 across General Payments, Research, and Ownership to 41 physicians and teaching hospitals across 68 transactions.
- $2.9M Top quartile payer
- All-tracks total
- 68 Below-median volume
- Transactions
- 41 Below-median reach
- Recipients
- #369
- of 1,925 companies
Cortex, Inc. reported $2,927,840.72 across all CMS Open Payments tracks (General + Research + Ownership) to 41 physicians and teaching hospitals in Program Year 2024 - ranking #369 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $145,672.03, averaging $71.4K per recipient.
How Cortex, Inc.'s $2.9M all-tracks total breaks down
Cortex, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
37/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer cortex-inc Cortex, Inc.
$2.9M · #369/1,925 · 0.0% industry · PY2024
- TOT $2.9M
- RANK #369
- SHARE 0.0%
- TXN 68
- RCP 41
- CAT 3
- GEN $145.7K
- TOP1 82.4%
- PY 2024
Volume peers
Nearest volume peer: Mylan Specialty L.P. ($2.9M)
Cortex, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Cortex, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Cortex, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
12 transactions worth $120.0K make "Consulting Fee" the top general-payment category in the 3-category breakdown below, 82.4% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Cortex, Inc. made 3 types of general payments. "Consulting Fee" is the largest category at $120.0K, 82.4% of General Payments.
How Cortex, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $120.0K | 12 | 82.4% |
| Compensation for Faculty or Speaker (Medical Education) | $23.4K | 7 | 16.1% |
| Food and Beverage | $2.3K | 22 | 1.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $144,017.85 (98.9%) of $145,672.03 in this company's General Payments records across 22 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Cortex, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Boaz Avitall
$120,000.00 across 12 reported transactions
- 2
Kent Nilsson
$11,673.40 across 5 reported transactions
- 3
Wilber Su
$6,172.22 across 3 reported transactions
- 4
David Haines
$3,172.23 across 2 reported transactions
- 5
Atul Verma
$3,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Cortex, Inc.'s spend rank (#369 of 1,925, top 19% by spend) and concentration rank (#233 of 1,838, top 13% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Accufix Surgical Inc. : $16.4K total payments, HHI 7031
- Genentech, Inc. : $59.4M total payments, HHI 6977
- Surgi-Care, Inc. : $31.9K total payments, HHI 6940
- Myomo, Inc : $9.3K total payments, HHI 6932
- Heidelberg Engineering, Inc. : $361.5K total payments, HHI 6929
- Potrero Medical, Inc. : $33.9K total payments, HHI 6915
- Cortex, Inc. (this company) : $145.7K total payments, HHI 6877
- Vy Spine LLC : $143.43 total payments, HHI 6811
- IZI Medical Products, LLC : $59.6K total payments, HHI 6805
- Lexington Medical, Inc. : $67.4K total payments, HHI 6779
- Milestone Scientific Inc. : $1.3M total payments, HHI 6693
- Volpara Health, Inc : $152.0K total payments, HHI 6645
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Cortex, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Cortex, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Cortex, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Instrumentation Laboratory Company
CathWorks, Inc.
Senseonics, Incorporated
Medline Industries LP
Mirum Pharmaceuticals, Inc.
Put this to use
Cortex, Inc. ranks #369 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Cortex, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Cortex, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.